Bluesail Medical

Bluesail Medical is a prominent global medical device manufacturer headquartered in China, recognized for its leadership in both medical consumables and high-end interventional cardiology products. The company operates three core business pillars: Health Protection, which produces billions of medical gloves annually; Cardiovascular Intervention, bolstered by the acquisition of Biosensors International; and Emergency Care, focused on first aid solutions. Its cardiovascular portfolio features innovative drug-eluting stents like BioMatrix and BioFreedom, which utilize the proprietary Biolimus A9 drug. Bluesail maintains a significant global footprint with R&D and manufacturing facilities across China, Singapore, and Europe, serving healthcare providers in over 100 countries. The company is publicly traded on the Shenzhen Stock Exchange and continues to expand into structural heart therapies and advanced surgical consumables.